• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Appalachian Diversion Aversion: Pain Management Pearls - WV Approved -

Program Type

Monograph

Credits

3 Contact Hour(s)

Release Date

Tuesday, May 14, 2019

Offline Date:

Sunday, May 1, 2022

ACPE Expiration Date

Sunday, May 1, 2022

Target Audience

Nurse, Pharmacist

Cost

$21.00

  • Overview

    We live in an “Opioid Crisis” where someone dies approximately every 7 minutes from drug overdose. So just how do we end this “Opioid Crisis”, or at least, how do we as healthcare professionals contribute to the progress of society in the right direction? In this monograph, we will review overall pain management etiology; numerous non-pharmacological and pharmacological treatment options (with particular attention on opioid medications), opioid overdose reversal treatments; along with not only how to identify drug seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. The West Virginia Controlled Substances Monitoring Program (CSMP) will of course also be discussed for its expected impact on adherence and diversion. We will also review West Virginia specific controlled substance laws and trends such as controlled substance classifications, prescribing authorities, the Opioid Reduction Act of 2018, the naloxone standing order, and DEA Red Flags. Unlike opioids, this monograph is intended to open one’s eyes, elevate blood pressure and/or heart rate, and increase cognition (in relation to the Opioid Crisis).


    This program has been APPROVED for WV Pharmacists to fulfill the requirement of Drug Diversion.  2019-06-01-DDT


    Handouts

    Homestudy PDF:   19068H03.pdf

    Financial Support By

    PharmCon, Inc.
  • Nurse

    Recognize the etiology and epidemiology of chronic pain.
    Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
    Identify when and how to initiate, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines.
    Recognize the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.
    Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
    Recognize the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.
    Identify how to be compliant with federal and state-controlled substances laws.
    Identify how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code§ 60A-9-l.
    Describe West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.


    Pharmacist

    Recognize the etiology and epidemiology of chronic pain.
    Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
    Identify when and how to initiate, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines.
    Recognize the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.
    Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
    Recognize the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.
    Identify how to be compliant with federal and state-controlled substances laws.
    Identify how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code§ 60A-9-l.
    Describe West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-19-068-H03-N

    Pharmacist 0798-0000-19-068-H03-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher
Adobe Acrobat Reader


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.